The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
NCT01811927 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2015-03-24
Summary
The purpose of this study is to the assess the clinical performance of the BIOTRONIK PRO-Kinetic Energy stent in subjects with atherosclerotic disease of native coronary arteries.
Conditions
Interventions
- DEVICE
-
PRO-Kinetic Energy Stent
Bare-metal stent
Sponsors & Collaborators
-
Biotronik AG
lead INDUSTRY
Principal Investigators
-
Christoph Kaiser, Prof · University Hospital of Basel
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- Netherlands
- Switzerland
Study Locations
More Related Trials
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
NCT01760083 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease
NCT01004575 ·Status: COMPLETED ·Phase: NA
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
Covered Stents in Treatment of Coronary Artery Perforation
NCT04630314 ·Status: COMPLETED
-
First in Man Trial - BIOSOLVE-I
NCT01168830 ·Status: COMPLETED ·Phase: NA
-
A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions
NCT01909869 ·Status: COMPLETED ·Phase: NA
-
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
NCT04192747 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
NCT02176265 ·Status: COMPLETED ·Phase: NA
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions
NCT00540813 ·Status: COMPLETED ·Phase: NA
-
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00232739 ·Status: COMPLETED ·Phase: PHASE3
-
Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease
NCT00744107 ·Status: UNKNOWN ·Phase: PHASE2
-
First in Men Study: BIOMAG-I
NCT04157153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630 ·Status: RECRUITING ·Phase: NA
-
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
NCT01093391 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
NCT06675617 ·Status: RECRUITING ·Phase: NA
-
BIONICS - Pharmacokinetics (PK) Trial
NCT02736344 ·Status: COMPLETED
-
A Study of the Presillion Stent in de Novo Coronary Lesions
NCT00722579 ·Status: COMPLETED ·Phase: PHASE3
-
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
NCT00233805 ·Status: COMPLETED ·Phase: PHASE2
-
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895 ·Status: COMPLETED ·Phase: PHASE4